X
Facebook
LinkedIn

Donate now

Home
Meet WAPO
Membership
News & events
Pituitary disorders
Library
- International Travel Letters
- Health and Exercises Information
Contact
Search
Menu Menu

WS21 – Use of Biosimilars in Endocrinology

Share this entry

Share on Facebook
Share on X
Share on X
Share on LinkedIn

https://www.wapo.org/wp-content/uploads/2023/02/WS21-eSummit-logo.png 575 1047 Muriël Marks https://www.wapo.org/wp-content/uploads/2023/05/logo-wapo-2023-1030x1030.png Muriël Marks2021-03-20 13:29:432023-02-20 11:32:13WS21 – Use of Biosimilars in Endocrinology

You might also like

WS22 – Bone Density – Natasha Appelman

Webinar 6 – B. Raimi-Abraham – Fight the Fakes

WS19 – Effective Communication with patients in difficult situations

WS22 – Shaping the Future of Endocrinology by Dirk De Rijdt

WS22 – SPA – Patient-Person Centred Care in Pituitary Disorders – Nienke Biermasz

Webinar 6 – B. Raimi-Abraham – Fight the Fakes (ES)

WS22 – SPA – Bone Density – Natasha Appelman-Dijkstra

Webinar 7 – J.G. Beun – Labor and Chronic Illness

Contact information

The World Alliance of Pituitary Organizations (WAPO) is a self-governed non-profit organization.

Terms and conditions

World Alliance of Pituitary Organizations
(association)

Chamber of Commerce: NL 66133 890
RSIN: 856 409 133

Rabobank – The Netherlands
IBAN: NL57 RABO 0311 2924 96
BIC: RABONL2U

WAPO Summit foundation
Rabobank – The Netherlands
IBAN: NL03 RABO 0304 5679 73
BIC: RABONL2U

More information

Pituitary Disorders

© Copyright WAPO | Kwaaijongens, rebels in oplossingen

X
Facebook
LinkedIn

Change cookie preferences
Privacy statement

WS21 – Pituitary Adenomas in Pregnancy

WS21 – Use of Biosimilars in Endocrinology (ES)

Scripts zijn geblokkeerd, bij het invullen van contactgegevens is het privacy statement van toepassing Lees meer